ROTHBLATT MARTINE A 13D and 13G filings for United Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 4:30 pm Sale | 2024-09-30 | 13G | United Therapeutics Corporation UTHR | ROTHBLATT MARTINE A | 3,194,162 6.800% | -706,146 (-18.10%) | Filing |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | United Therapeutics Corporation UTHR | ROTHBLATT MARTINE A | 3,900,308 7.800% | -19,295 (-0.49%) | Filing |
| 2023-02-02 06:02 am Sale | 2022-12-31 | 13G | United Therapeutics Corporation UTHR | ROTHBLATT MARTINE A | 3,919,603 8.000% | -198,884 (-4.83%) | Filing |
| 2022-02-04 4:31 pm Purchase | 2021-12-31 | 13G | United Therapeutics Corporation UTHR | ROTHBLATT MARTINE A | 4,118,487 8.500% | 489,001 (+13.47%) | Filing |
| 2021-03-01 4:30 pm Purchase | 2020-12-31 | 13G | United Therapeutics Corporation UTHR | ROTHBLATT MARTINE A | 3,629,486 7.600% | 3,629,486 (New Position) | Filing |